NeuroSense Therapeutics
NRSN
NRSN
5 hedge funds and large institutions have $132K invested in NeuroSense Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
5
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$261K | |
| 2 | -$168K | |
| 3 | -$68K | |
| 4 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
-$41.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$33K |